Clinical Trial Update: 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs [Phase 3]

View source ↗

Summary

Completed Phase 3 trial evaluating three-year efficacy and safety of zoledronic acid in post-menopausal osteoporosis patients who previously received zoledronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-menopausal Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Post-menopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2013-12-30